| __timestamp | Ionis Pharmaceuticals, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 1643000000 |
| Thursday, January 1, 2015 | 37173000 | 1532000000 |
| Friday, January 1, 2016 | 48616000 | 1364000000 |
| Sunday, January 1, 2017 | 108488000 | 1334000000 |
| Monday, January 1, 2018 | 244622000 | 1484000000 |
| Tuesday, January 1, 2019 | 287000000 | 1638000000 |
| Wednesday, January 1, 2020 | 354000000 | 1726000000 |
| Friday, January 1, 2021 | 186000000 | 2001000000 |
| Saturday, January 1, 2022 | 151000000 | 2009000000 |
| Sunday, January 1, 2023 | 232600000 | 2151000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic growth. From 2014 to 2023, Zoetis Inc. and Ionis Pharmaceuticals, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Zoetis, a leader in animal health, consistently outspent Ionis, with its SG&A expenses peaking at approximately $2.15 billion in 2023, marking a 31% increase from 2014. In contrast, Ionis, a pioneer in RNA-targeted therapeutics, saw its SG&A expenses rise by over 1,000% during the same period, reaching around $232 million in 2023. This stark contrast highlights Zoetis's stable growth and Ionis's aggressive expansion strategy. As the pharmaceutical landscape continues to shift, these spending patterns offer valuable insights into each company's operational focus and market positioning.
AbbVie Inc. vs Zoetis Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Sanofi vs Ionis Pharmaceuticals, Inc.
Gilead Sciences, Inc. and Zoetis Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Zoetis Inc. vs Teva Pharmaceutical Industries Limited Trends and Insights
SG&A Efficiency Analysis: Comparing Zoetis Inc. and Neurocrine Biosciences, Inc.
Cost Management Insights: SG&A Expenses for Zoetis Inc. and Mesoblast Limited
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Viridian Therapeutics, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Ionis Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Blueprint Medicines Corporation or Ionis Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Ionis Pharmaceuticals, Inc. and Veracyte, Inc.
Ionis Pharmaceuticals, Inc. vs Evotec SE: SG&A Expense Trends